NICE has said that the NHS should not fund Bristol-Myers Squibb’s multiple sclerosis pill Zeposia (ozanimod) for relapsing multiple sclerosis in first draft guidance. The cost-effectiveness body ...

The MS Trust patient group said in a statement that it was disappointed with NICE’s decision given that Zeposia has few side-effects. While Biogen’s Tecfidera pill is effective it is notorious ...

The price you pay for Zeposia (ozanimod) may depend on factors such as whether you have health insurance and the pharmacy you use. Financial assistance may be available to help with the cost.

Zeposia, an ulcerative colitis medication, ran Z The Light, a direct-to-consumer campaign aimed at driving awareness, intent to ask doctors for the brand, prescriptions and brand equity. Summary of ...

Zeposia has been developed for adult patients with relapsing remitting MS, where the patient has flare-ups followed by periods of remission. It is a treatment option which may reduce the need to ...